Richard Cook
Corporate Officer/Principal en University of British Columbia .
Perfil
Richard Cook is an Associate Professor at the University of British Columbia, where he has been working since 2013.
Prior to his current position, he worked as the Chief Medical Officer at Avagenesis Corp.
and Enlighta, Inc. Cook holds a doctorate degree from the University of Alberta and a graduate degree from the University of British Columbia.
Cargos activos de Richard Cook
| Empresas | Cargo | Inicio |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | 01/01/2013 |
Antiguos cargos conocidos de Richard Cook.
| Empresas | Cargo | Fin |
|---|---|---|
| ENLIGHTA INC. | Director Técnico/Científico/I+D | - |
Avagenesis Corp.
 Avagenesis Corp. Miscellaneous Commercial ServicesCommercial Services Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada. | Director Técnico/Científico/I+D | - |
Formación de Richard Cook.
| University of Alberta | Doctorate Degree |
| University of British Columbia | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENLIGHTA INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Avagenesis Corp.
Avagenesis Corp. Miscellaneous Commercial ServicesCommercial Services Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada. | Commercial Services |
- Bolsa de valores
- Insiders
- Richard Cook